case report aspiration during anesthesia semaglutide 2023 GLP-1 semaglutide anesthesia endoscopy case report aspiration glp-1 receptor
Description
This allows more water absorption from stool in the colon, resulting in harder, more difficult-to-pass stools
Most patients achieve 815 pounds of total weight loss by the end of week 12, with the majority of this coming from fat tissue rather than water
Novo Nordisk holds patents on semaglutide extending through 2032 and beyond
The goal is to maximize nutrition within a naturally smaller eating window
Similarly, metformin is safe and well-tolerated with long-term use
